Viatris | VTRS - Ordinary Share Capital



Viatris reported $1.17B in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Adcock Ingram Holdings ZAR 14.68M 0 Dec/2024
Celltrion KRW 230.8B 10.29B Mar/2025
Cspc Pharmaceutical CNY 11.03B 26.91M Dec/2024
Dianthus Therapeutics USD 32.18M 32.15M Jun/2025
Divis Laboratories Ltd 530M 0 Mar/2025
Kangmei Pharma CNY 13.86B 0 Jun/2025
Knight Therapeutics CAD 539.32M 1.63M Sep/2024
Laboratorios Farma EUR 3.24M 0 Jun/2023
Malin Corporation EUR 200K 0 Dec/2024
Medical Developments International AUD 115.01M 9.28M Dec/2024
Neuren Pharmaceuticals AUD 165.27M 10.43M Dec/2024
Organigram Holdings CAD 134.02M 758.57M Jun/2025
Pharma Mar EUR 17.58M 6.64M Jun/2025
Qiagen NV USD 216.83M 214.3M Jun/2025
Sartorius EUR 69.04M 38.2K Jun/2025
Sino Biopharmaceutical CNY 414.38M 0 Dec/2024
Tilray USD 93K 5K Nov/2024
Viatris USD 1.17B 1.15B Jun/2025
Zz Pientze Pharmaceu 603.32M 0 Jun/2025